Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 80: 341-344, 1996;
8750-7587/96 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scuri, M.
Right arrow Articles by Wanner, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scuri, M.
Right arrow Articles by Wanner, A.

Journal of Applied Physiology, Vol 80, Issue 1 341-344, Copyright © 1996 by American Physiological Society

ARTICLES

Effect of inhaled and intravenous acetylcholine on bronchial blood flow in anesthetized sheep

M. Scuri, V. McCaskill, A. D. Chediak, W. M. Abraham and A. Wanner
Division of Pulmonary Disease, University of Miami School of Medicine at Mount Sinai Medical Center, Florida 33140, USA.

The reported effects of cholinergic agonists on bronchial blood flow (Qbr) have been inconsistent. The aim of the present study was to determine whether the inconsistency could be due to the mode of agonist administration (systemic vs. aerosol) or the anatomic site of blood flow in the bronchus (mucosal vs. deep wall). In 10 anesthetized mechanically ventilated adult sheep, we measured Qbr in main bronchi by color-coded microspheres, systemic and pulmonary arterial pressures, cardiac output, and lung resistance (RL) before and after acetylcholine (ACh) administered either as an aerosol (nebulized dose 100 micrograms) or as an intravenous bolus (2 micrograms/kg). Before drug administration, 72% of mean Qbr was distributed to the bronchial mucosa and the remainder was distributed to the deep bronchial wall. For a comparable increase in mean RL (150% for intravenous ACh and 205% for aerosol ACh), mean total Qbr normalized for systemic arterial pressure increased by 291% after intravenous ACh (P < 0.05) and decreased by 9% after aerosol ACh (not significant). Mucosal and deep wall Qbr increased proportionally. Atropine (0.2 microgram/kg) prevented the changes in Qbr and RL after intravenous ACh. Thus intravenous but not aerosol ACh increased blood flow in the mucosa and deep wall of extrapulmonary bronchi. This suggests that the muscarinic receptors mediating vasodilation are more accessible to intravascular than intrabronchial ACh.


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
J. Brieva and A. Wanner
Adrenergic airway vascular smooth muscle responsiveness in healthy and asthmatic subjects
J Appl Physiol, February 1, 2001; 90(2): 665 - 669.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
P. Carvalho, W. H. Thompson, and N. B. Charan
Comparative effects of alpha -receptor stimulation and nitrergic inhibition on bronchovascular tone
J Appl Physiol, May 1, 2000; 88(5): 1685 - 1689.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
N. B. Charan, P. Carvalho, S. R. Johnson, W. H. Thompson, and S. Lakshminarayan
Effect of aerosolized acetylcholine on bronchial blood flow
J Appl Physiol, August 1, 1998; 85(2): 432 - 436.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
E. M. Wagner and R. H. Brown
Blood flow distribution within the airway wall
J Appl Physiol, May 1, 2002; 92(5): 1964 - 1969.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online